Posts tagged india

Dr. Unni Karunakara started biking the entire length of India, from Srinagar in Kashmir to Thiruvanathapuram in Kerala, in October 2013. The former international president of MSF has now biked more than 3290 miles or 5300 km, having made many stops along the way to talk to medical students about health and humanitarianism. See photos and his blog UnniCycles:https://www.cycleformsf.in/unnicycles/

Dr. Unni Karunakara started biking the entire length of India, from Srinagar in Kashmir to Thiruvanathapuram in Kerala, in October 2013. The former international president of MSF has now biked more than 3290 miles or 5300 km, having made many stops along the way to talk to medical students about health and humanitarianism. See photos and his blog UnniCycles:https://www.cycleformsf.in/unnicycles/

Damaging intellectual property rules in the U.S.-led Trans-Pacific Partnership Agreement (TPP) would give pharmaceutical companies longer monopolies over brand name drugs. Companies would be able to charge high prices for longer periods of time. And it would be much harder for generic companies to produce cheaper drugs that are vital to people’s health. We need your help:http://www.doctorswithoutborders.org/take-action/tpp/

Damaging intellectual property rules in the U.S.-led Trans-Pacific Partnership Agreement (TPP) would give pharmaceutical companies longer monopolies over brand name drugs. Companies would be able to charge high prices for longer periods of time. And it would be much harder for generic companies to produce cheaper drugs that are vital to people’s health. We need your help:http://www.doctorswithoutborders.org/take-action/tpp/

MSF’s outgoing international president, Dr. Unni Karunakara, left Sunday on a journey by bicycle from one end of India to the other. It’s a 3,000+ mile (5000 km) journey that Unni will use to spark a dialogue on health, healthcare, and humanitarianism. You can follow his progress here: https://www.cycleformsf.in/unnicycles/

MSF’s outgoing international president, Dr. Unni Karunakara, left Sunday on a journey by bicycle from one end of India to the other. It’s a 3,000+ mile (5000 km) journey that Unni will use to spark a dialogue on health, healthcare, and humanitarianism. You can follow his progress here: https://www.cycleformsf.in/unnicycles/

Illustration: This is in Bandra again, in a slum. This is a drug-resistant TB patient with HIV as well. He was happy to have us there and let us draw him and talk to him, and the stigma wasn’t an issue for him. This is really a description of the outside of the house where he lives with his mum and his other brother. She’s raised six children here; he sleeps outside as a sort of precaution, she sleeps inside, and this is his bed which is covered up by bits of plastic bags and propped up by pillars and corrugated iron. It gives you an idea of the sort of places that [MSF’s patients] are living in, and living in when they’ve got this horrible disease. India 2013 © George Butler
MSF’s HIV/TB Project in Mumbai
MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.

Illustration: This is in Bandra again, in a slum. This is a drug-resistant TB patient with HIV as well. He was happy to have us there and let us draw him and talk to him, and the stigma wasn’t an issue for him. This is really a description of the outside of the house where he lives with his mum and his other brother. She’s raised six children here; he sleeps outside as a sort of precaution, she sleeps inside, and this is his bed which is covered up by bits of plastic bags and propped up by pillars and corrugated iron. It gives you an idea of the sort of places that [MSF’s patients] are living in, and living in when they’ve got this horrible disease. India 2013 © George Butler

MSF’s HIV/TB Project in Mumbai

MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.

Illustration: India 2013 © George Butler
MSF’s HIV/TB Project in Mumbai
MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.

Illustration: India 2013 © George Butler

MSF’s HIV/TB Project in Mumbai

MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.

59 plays

NPR reports on this week’s landmark ruling by India’s Supreme Court that means Indian generic drug manufacturers can keep producing affordable medicines for use in developing countries. Learn more about drug patents.

Photo: Hundreds of activists gathered in New Delhi to protest Novartis’s attack on India’s patent laws in 2007. MSF and others continue to oppose the legal case today. India 2007 © MSF
The Novartis Drop the Case Campaign
Yesterday, India’s Supreme Court upheld India’s Patent Act in the face of a seven-year challenge by Swiss pharmaceutical company Novartis.

Photo: Hundreds of activists gathered in New Delhi to protest Novartis’s attack on India’s patent laws in 2007. MSF and others continue to oppose the legal case today. India 2007 © MSF

The Novartis Drop the Case Campaign

Yesterday, India’s Supreme Court upheld India’s Patent Act in the face of a seven-year challenge by Swiss pharmaceutical company Novartis.

Indian Supreme Court Decision on Novartis Case a Victory for Access to Medicines in Developing Countries

“This is a huge relief for the millions of patients and doctors in developing countries who depend on affordable medicines from India, and for treatment providers like MSF,” said Dr. Unni Karunakara, MSF’s international president.

BREAKING NEWSNovartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries. 

BREAKING NEWS
Novartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries. 

Rape is a crime that affects many aspects of human life; it is a medical emergency, it is a psychological trauma and it has deep consequences on both family and societal level. It is of utmost importance that survivors of rape have access to immediate medical and psychological care, and also for the sake of preventing sexual violence altogether in a long-term perspective it is important that women’s rights in general are improved.
MSF Mental Health Officer, Minja, reflects on the horrors of gang rape. Her main role is providing mental health care and psychological support for victims of family and sexual violence, mainly with female patients in Papua New Guinea. Please leave your questions and comments for Minja below her blog post.
The day-to-day purpose of the project here is to heal kids like George of their severe acute malnutrition, so that they avoid stunting or, worse, death, and you could no more quantify this benefit than you could put a price on a human life. But MSF is here with an additional, even more ambitious goal: if we can help kids like George with a model of community based nutritional care tailor-made specifically for the Bihar State, India setting, then we might just be able to convince the government to adopt this model of care, scale it up and then help every sick kid like George.
MSF doctor, Luke Chapman, on his work with malnutrition in Bihar state, India. Please leave your questions and comments for Luke in the box below his blog post. 
But can you ‘treat’ malnutrition? Maybe there is something strange about putting illnesses which are directly caused by very specific parasites in the same bracket as one with “geosociopolitical” causes. The facts are plain though. Whether you choose to label it as a disease or not (and MSF does), you can do something about it, and that is what really matters.
MSF Launches Online Resource To Combat Unwarranted Drug Patent Requests

There are many reasons why people lack access to essential medicines, but one of the major barriers is the high price of drugs. Patents prevent the open competition that could drive prices down to lower, affordable levels. MSF Access Campaign launched an online database to help groups challenge unfair drug patents. Don’t give up. Keep up the fight!

patentoppositions.org

MSF Launches Online Resource To Combat Unwarranted Drug Patent Requests

There are many reasons why people lack access to essential medicines, but one of the major barriers is the high price of drugs. Patents prevent the open competition that could drive prices down to lower, affordable levels. MSF Access Campaign launched an online database to help groups challenge unfair drug patents. Don’t give up. Keep up the fight!

patentoppositions.org

Photo: Protesters carry signs outside Novartis’s Mumbai office on Worlds AIDS Day. India 2011 © Claudio Tommasini

Leena Menghaney: India’s Patent Law on Trial

In this piece from BMJ Group Blogs, lawyer and India manager of MSF’s Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India’s medicines patent law. Learn more at www.msfaccess.org

Photo: Protesters carry signs outside Novartis’s Mumbai office on Worlds AIDS Day. India 2011 © Claudio Tommasini

Leena Menghaney: India’s Patent Law on Trial

In this piece from BMJ Group Blogs, lawyer and India manager of MSF’s Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India’s medicines patent law. Learn more at www.msfaccess.org

This decision once again affirms that courts can and should act in the interest of public health in the case of pharmaceutical products.